Reducing racial disparities in prostate cancer survival
Friday, July 31st, 2009 Posted in prostate cancer | No Comments »The latest work of North Carolina-Louisiana Prostate Cancer Project reports new findings related to new targets for reducing racial disparities in prostate cancer survival and highlights the importance of the health care delivery system The study reveals that differences in physician ...
Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer remains controversial
Thursday, July 30th, 2009 Posted in prostatectomy, radiation therapy | No Comments »The use of immediate postoperative and salvage radiotherapy in high-risk patients after radical prostatectomy for prostate cancer remains controversial. Immediate postoperative radiotherapy improves biochemical and clinical progression-free survival in randomised trials. Metastasis-free survival and overall survival were seen to be ...
Few patients die from prostate cancer within 15 years of radical prostatectomy
Wednesday, July 29th, 2009 Posted in prostatectomy | No Comments »Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC), along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed a study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become ...
Most cancer patients not worried by delayed therapy
Tuesday, July 28th, 2009 Posted in prostate cancer | No Comments »A new Dutch research at Erasmus Medical Center in Rotterdam shows that men who delay treatment for their early prostate cancer are not especially anxious about living with the disease. According to Dr. Roderick van den Bergh and colleagues, the evidence ...
Current state of cryoablation of localized prostate cancer
Monday, July 27th, 2009 Posted in prostate cryotherapy | No Comments »Due to continuous technical developments for more than half a century followed by better clinical results with minimal side effects, cryoablation of the prostate for localized prostate cancer has evolved as a true alternative therapeutic option in selected cases. The current ...
Use of erectile aids in men treatet for localized prostate cancer
Sunday, July 26th, 2009 Posted in prostate cancer | No Comments »A research team at University of California-Los Angeles, Los Angeles, California, US, has recently evaluated associations between demographic and clinical characteristics, quality of life outcome measures and erectile aids in men treated for localized prostate cancer. All patients were initially diagnosed ...
Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer
Thursday, July 23rd, 2009 Posted in prostate cancer | No Comments »Sexual dysfunction might be symptomatic of cancer spreading beyond the prostate by local invasion, a mechanism of tumour progression associated with prognosis. Conversely, among men with raised prostate-specific antigen (PSA) levels, a negative association might be expected if sexual dysfunction ...
The optimal duration of neoadjuvant androgen deprivation in prostate cancer radiotherapy
Wednesday, July 22nd, 2009 Posted in hormone therapy | No Comments »According to previous studies, for locally advanced prostate cancer, the results of radiotherapy are improved by combination with androgen deprivation therapy. Volume reduction achieved with neoadjuvant hormonal treatment can facilitate dose escalation without increasing the toxicity. The main problem is the ...
Prostate cancer: Effects of interval between diagnosis and time of survey
Tuesday, July 21st, 2009 Posted in prostate cancer diagnosis | No Comments »A recent study at Department of Psychology, University of New England, Armidale, New South Wales, Australia aimed to determine whether time since diagnosis affected patients' evaluations of the information they had received at the time of their diagnosis. Previous data indicate ...
The effect of obesity and lower serum PSA levels on prostate-cancer screening
Monday, July 20th, 2009 Posted in prostate cancer diagnosis | No Comments »A study at University of Washington, Seattle, WA, USA. has targeted to determine if lower serum total prostate specific antigen (PSA) levels in obese American men affect prostate-cancer screening results. The researchers were interested about the subject as an increased ...